Federal regulators on Wednesday approved Eli Lilly’s new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions.The Food and Drug ...
Tripling the dose of Novo Nordisk’s obesity treatment led to increased weight loss in patients during a clinical trial, as the company seeks to broaden ...
US pharmaceutical group Eli Lilly has announced that the latest trial of its anti-obesity pill has met weight-loss targets, boosting its plans to seek approval ...
Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a ...
The World Health Organization (WHO) on Thursday announced its support for weight-loss drugs in adults globally.The organization plans to back GLP-1s like Wegovy and Zepbound ...
This would broaden access to these jabs considerably, as the health service currently restricts injections to those regarded as having the highest clinical need.Weight loss ...